Formation of stacking complexes between caffeine (1,2,3-trimethylxanthine) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine may attenuate biological effects of this neurotoxin.

Bioorganic chemistry2005Ulanowska K, Piosik J, Gwizdek-Wiśniewska A, et al.

Study designOther primary literature

SubjectHuman & animal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAnimalsCaffeineCalorimetryHumansModels, MolecularMutagenicity TestsNeurotoxinsParkinsonian DisordersVibrio

DOI 10.1016/j.bioorg.2005.07.004

PMID 16165186

View source →